|
Jul 18
|
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
|
|
Jun 26
|
NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation
|
|
Jun 24
|
NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement
|
|
Jun 11
|
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System
|
|
Jun 4
|
NanoVibronix Announces CEO Transition
|
|
Apr 11
|
NanoVibronix Regains Nasdaq Compliance
|
|
Mar 14
|
Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal
|
|
Mar 12
|
NanoVibronix Announces Reverse Stock Split
|
|
Feb 14
|
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.
|
|
Sep 23
|
NanoVibronix Signs Letter of Intent with Potential New Distributor
|
|
May 16
|
NanoVibronix Issues Letter to Stockholders
|
|
May 14
|
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
|
|
May 1
|
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
|
|
Dec 6
|
NanoVibronix Featured in Your Bladder Health Magazine
|
|
Dec 4
|
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
|
|
Nov 28
|
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
|
|
Nov 14
|
NanoVibronix Issues Letter to Shareholders
|
|
Nov 7
|
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
|